The U.S. Food and Drug Administration on Friday approved Biogen https://www.reuters.com/markets/companies/BIIB.O” target=”_blank” rel=”noopener”>(BIIB.O) and Sage Therapeutics’ https://www.reuters.com/markets/companies/SAGE.O” target=”_blank” rel=”noopener”>(SAGE.O)<…
Read More
About The Author
